513 related articles for article (PubMed ID: 26729459)
21. Mycophenolate mofetil in lupus nephritis.
Ginzler EM; Aranow C
Lupus; 2005; 14(1):59-64. PubMed ID: 15732290
[TBL] [Abstract][Full Text] [Related]
22. New and future therapies for lupus nephritis.
Appel GB
Cleve Clin J Med; 2012 Feb; 79(2):134-40. PubMed ID: 22301564
[TBL] [Abstract][Full Text] [Related]
23. Con: Cyclophosphamide for the treatment of lupus nephritis.
Mok CC
Nephrol Dial Transplant; 2016 Jul; 31(7):1053-7. PubMed ID: 27190358
[TBL] [Abstract][Full Text] [Related]
24. Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis.
Lenz O; Fornoni A; Contreras G
Drugs; 2005; 65(17):2429-36. PubMed ID: 16296869
[TBL] [Abstract][Full Text] [Related]
25. [Clinical guideline for the treatment of lupus nephritis and single-centre results of mycofenolate mofetil among patients with lupus nephritis in the National Institute of Rheumatology and Physiotherapy, Budapest].
Szabó MZ; Kiss E
Orv Hetil; 2016 Aug; 157(35):1385-93. PubMed ID: 27569461
[TBL] [Abstract][Full Text] [Related]
26. Con: The use of calcineurin inhibitors in the treatment of lupus nephritis.
Fernandez Nieto M; Jayne DR
Nephrol Dial Transplant; 2016 Oct; 31(10):1567-71. PubMed ID: 27591328
[TBL] [Abstract][Full Text] [Related]
27. Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil.
Lau KK; Ault BH; Jones DP; Butani L
J Pediatr Health Care; 2008; 22(5):282-8. PubMed ID: 18761229
[TBL] [Abstract][Full Text] [Related]
28. Induction and maintenance therapy in proliferative lupus nephritis.
Ponticelli C; Glassock RJ; Moroni G
J Nephrol; 2010; 23(1):9-16. PubMed ID: 20091481
[TBL] [Abstract][Full Text] [Related]
29. Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis.
Walsh M; James M; Jayne D; Tonelli M; Manns BJ; Hemmelgarn BR
Clin J Am Soc Nephrol; 2007 Sep; 2(5):968-75. PubMed ID: 17702723
[TBL] [Abstract][Full Text] [Related]
30. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
Sixdorf U; Bauer H; Märker-Hermann E
Dtsch Med Wochenschr; 2006 Oct; 131(41):2266-9. PubMed ID: 17036267
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of a mycophenolate mofetil-refractory proliferative lupus nephritis with Belimumab in a 19-year-old woman.
Fließer EE; Korsten P; Koziolek MJ; Niewold TB; Patschan D; Müller GA; Patschan SA
Lupus; 2013 Dec; 22(14):1523-5. PubMed ID: 24014569
[TBL] [Abstract][Full Text] [Related]
32. Updates on the treatment of lupus nephritis.
Bomback AS; Appel GB
J Am Soc Nephrol; 2010 Dec; 21(12):2028-35. PubMed ID: 21051743
[TBL] [Abstract][Full Text] [Related]
33. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide.
Glicklich D; Acharya A
Am J Kidney Dis; 1998 Aug; 32(2):318-22. PubMed ID: 9708620
[TBL] [Abstract][Full Text] [Related]
34. Human clinical trials in lupus nephritis.
Dooley MA; Falk RJ
Semin Nephrol; 2007 Jan; 27(1):115-27. PubMed ID: 17336693
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
Choi CB; Won S; Bae SC
Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
[TBL] [Abstract][Full Text] [Related]
36. Current status of lupus nephritis.
Jaryal A; Vikrant S
Indian J Med Res; 2017 Feb; 145(2):167-178. PubMed ID: 28639592
[TBL] [Abstract][Full Text] [Related]
37. Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclosphosphamide and cyclosporine.
Fu YF; Liu GL
Clin Nephrol; 2001 Apr; 55(4):318-21. PubMed ID: 11334319
[TBL] [Abstract][Full Text] [Related]
38. Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.
Mak A; Cheak AA; Tan JY; Su HC; Ho RC; Lau CS
Rheumatology (Oxford); 2009 Aug; 48(8):944-52. PubMed ID: 19494179
[TBL] [Abstract][Full Text] [Related]
39. Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?
Rovin BH; Parikh SV; Hebert LA; Chan TM; Mok CC; Ginzler EM; Hooi LS; Brunetta P; Maciuca R; Solomons N
Clin J Am Soc Nephrol; 2013 Jan; 8(1):147-53. PubMed ID: 22879439
[TBL] [Abstract][Full Text] [Related]
40. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
